We did not observe this dependency which may well represent the differences in B-cell lymphoma model, where we used the λ-Myc mouse model and the other researchers used Eμ-Myc mice, a model where Myc is driven by an enhancer/promoter element that is activated earlier in the B-cell development than is the λ enhancer/promoter. Here, MYC is linked to B-cell non-Hodgkin lymphoma.